JScope
Start free trial
Home / Projects / Pharma & medical
Factory/PlantPharma & medical

GC Corporation to build new biomaterials plant at Fuji-Oyama site

GC CorporationOyama, ShizuokaPublished
InvestmentNot disclosed
PhaseUnder construction
StartJun 2026
CompletionNov 2027
Construction
Today
2027

About 13 months to scheduled completion.

Dental materials maker GC Corporation is constructing a new biomaterials factory at its Fuji-Oyama plant site in Oyama Town, Shizuoka Prefecture, to expand production of bone graft materials and resorbable membranes. Chiyoda Ex-One Engineering is handling design and EPC construction with partners Kajima Corporation, Techno Ryowa, and Kandenko; construction began in June 2026 with completion targeted by November 30, 2027.

Project facts

Owner
GC Corporation
Facility
Factory/Plant
Sector
Pharma & medical
Location
Oyama, Shizuoka, Japan
Investment
Not disclosed
Contractor
Chiyoda Ex-One Engineering
Construction start
Jun 2026
Completion
Nov 2027
Announced
May 19, 2026

Figures and schedules are as announced by the company or the public body concerned; plans can change. Amounts that were not disclosed are recorded as not disclosed, never estimated.

Also in Shizuoka7 projects · ¥3B disclosedOn the map →

OKI to build new production building at Numazu Plant for defense underwater acousticsOKI Electric Industry Co., Ltd.Planned¥3BReene Energy and Appletree to develop grid-scale battery storage facility in KakegawaReene Energy Co., Ltd.Plannedn/dChubu Nippon Plastic adds two tent warehouses at its headquarters factoryChubu Nippon PlasticCompletedn/dRENOVA to develop 99.9 MW / 280 MWh battery storage facility in Fukuroi, ShizuokaRENOVA, Inc.Plannedn/d

Latest in Pharma & medicalAll Pharma & medical →

Fujifilm to install ADC raw-material manufacturing equipment at Hirono plant

NewPharma & medicalFukushimaPlanned

Fujifilm will install payload and linker-payload manufacturing equipment, including reaction vessels, a filtration dryer and a preparative HPLC system, at the Hirono plant in Fukushima. The facility will also add a laboratory for process and analytical-method development, with operations scheduled to begin in 2028, enabling Fujifilm's one-stop domestic ADC CDMO service.

Shikoku Chuken to build new headquarters and research facility in Ayagawa

Pharma & medicalKagawaPlanned

Shikoku Chuken will build a new headquarters facility on land adjacent to its existing headquarters in Ayagawa, Kagawa. The facility will expand research and development using clinical specimens and testing data collected from across Shikoku, along with corporate planning, information processing and administrative functions; operations are scheduled to begin in January 2028.

Olympus completes new B Building at Nagano site for medical-device component production

Pharma & medicalNaganoCompleted¥18B

Olympus has completed the new B Building at its Nagano site in Tatsuno, Nagano, consolidating development and manufacturing functions and establishing a production base for key medical-device components. Construction began in February 2025, with full operation targeted for FY2026; the building has 17,665 sqm of total floor area and a total construction cost of approximately ¥18 billion.

JGC completes Chugai Pharma's UT3 biopharmaceutical API facility in Utsunomiya

Pharma & medicalTochigiCompleted

JGC Holdings completed the UT3 biopharmaceutical active pharmaceutical ingredient facility for Chugai Pharmaceutical Industry at its Utsunomiya plant in May 2026. The four-story facility supports clinical-trial manufacturing through initial commercial production and includes continuous-production capabilities, solar panels and other environmental features; it was handed over on May 14, 2026.